Alaunos Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2011 | — | -41,680.6% | -58,220.9% |
| Jun 2011 | — | -6,424.0% | -5,362.0% |
| Sep 2011 | — | -7,104.5% | -401.0% |
| Dec 2011 | — | -8,208.5% | -6,622.0% |
| Mar 2012 | — | -9,316.5% | -12,235.0% |
| Jun 2012 | — | -11,483.0% | -11,806.5% |
| Sep 2012 | — | -10,863.5% | -8,912.0% |
| Dec 2012 | — | -19,421.5% | -15,112.5% |
| Mar 2013 | — | -11,791.5% | -6,399.5% |
| Jun 2013 | — | -9,148.0% | -9,346.0% |
| Sep 2013 | — | -4,557.5% | -8,356.5% |
| Dec 2013 | — | -3,359.5% | -4,451.5% |
| Mar 2017 | — | -874.5% | -1,230.9% |
| Jun 2017 | — | -814.9% | -1,110.0% |
| Sep 2017 | — | -818.4% | -1,101.6% |
| Dec 2017 | — | -841.3% | -1,144.1% |
| Mar 2018 | — | -11,093.2% | -14,479.5% |
| Sep 2021 | — | -5,602.0% | -5,711.8% |
| Sep 2022 | — | -283.9% | -304.1% |
| Jun 2023 | — | -199,550.0% | -219,325.0% |
| Dec 2023 | — | -794,900.0% | 2,261,800.0% |
| Mar 2024 | — | -174,200.0% | -168,200.0% |
| Jun 2024 | — | -29,150.0% | -28,225.0% |
| Dec 2024 | — | -15,080.0% | -14,820.0% |
| Mar 2025 | — | -54,600.0% | -53,650.0% |
| Dec 2025 | — | -30,233.3% | -29,766.7% |